Human Milk Fortifier and Cytokine Profile

This study has been completed.
Sponsor:
Information provided by:
Christiana Care Health Services
ClinicalTrials.gov Identifier:
NCT00601081
First received: January 15, 2008
Last updated: July 23, 2008
Last verified: July 2008

January 15, 2008
July 23, 2008
November 2007
June 2008   (final data collection date for primary outcome measure)
Cytokine profile pre and post initiation of HMF [ Time Frame: up to 14 days ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00601081 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Human Milk Fortifier and Cytokine Profile
Alterations in the Cytokine Profile of Premature Infants After Human Milk Fortifier

This is a research study investigating if adding human milk fortifier to a preterm babies breast milk feedings affects the baby's immune system.

In very low birth weight (VLBW) infants and preterm infants human milk fortifier (HMF) is often added to breast milk feedings in order to add extra calories, vitamins, and minerals. It is well known that breast milk feedings are easier to digest and have immune benefits compared to formula feedings. Cytokines, marker of immune function, can be found in blood, stool, and breast milk. This study involves collection of blood and stool samples to monitor cytokines. The purpose of this study is to understand whether human milk fortifier alters infants' cytokines.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Blood and stool

Non-Probability Sample

Infants hospitalized in the newborn intensive care unit.

Infant, Very Low Birth Weight
Not Provided
1
Very low birth weight and preterm infants who will likely receive fortification of breast milk with HMF
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
24
June 2008
June 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Infants born weighing less than 1500 grams
  • exclusive breast milk feedings with intention to fortify with human milk fortifier

Exclusion Criteria:

  • positive blood culture
  • history of necrotizing enterocolitis
  • significant lung disease at the start of the study
Both
up to 6 Months
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00601081
27127
No
Christopher Hsu, MD, Christiana Hospital
Christiana Care Health Services
Not Provided
Principal Investigator: Robert G. Locke, DO Christiana Hospital
Principal Investigator: Christopher T. Hsu, MD Christiana Hospital
Christiana Care Health Services
July 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP